NHS cuts and services: can we afford it?

Platform process will give platform product - Can we afford it?

Introduction Manufacturing processes for therapeutic monoclonal antibodies (mAbs) have evolved immensely in the past two decades around two major thrust areas. 1) Advancements in a) Cell line developmentbreakthrough and incremental knowledge gain in technology b) Media and feed formulation strategies c) Advent of Disposables and Instrumentation technologies thus offering significant improvement...

Ethics roundtable: 'Open-ended ICU care: Can we afford it?'

THE CASE The patient is a 27-year-old previously healthy male with a diagnosis of viral encephalitis with a lymphocytic pleocytosis on cerebrospinal fluid examination. For 3 months, he has been in status epilepticus (SE) on high doses of barbiturates, benzodiazepines, and ketamine and a ketogenic feeding-tube formula. He remains in burst suppression on continuous electroencephalography (EEG). H...

[Duplicate or redundant publication: can we afford it?].

Rev Esp Cardiol. 2005;58(5):601-4 601 REVISTA ESPAÑOLA DE CARDIOLOGÍA recently published the full text of the latest recommendations of the International Committee of Medical Journal Editors (ICMJE).1,2 One of the aspects of editorial ethics covered by these recommendations is redundant or duplicate publication. This journal is committed to a strict policy on this type of publication. Redundant...

Can We Afford It? Issues in Designing Transparent Technologies

Situated Action claims that action is guided by an environment featuring objects, including technologies, whose use is transparent to us. Work on affordances perceived properties of objects which, in the context of a given course of action, tell us directly what those objects are for helps explain this. It is argued that an affordance helps make a technology transparent because it is a function...

Can we afford not to have integrated dementia services?